Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hypoalbuminaemia as a Prognostic Biomarker of First-Line Treatment Resistance in Metastatic Non-small Cell Lung Cancer
Mark Stares, Amanda M. Swan, Kirsten Cumming, et al.
Frontiers in Nutrition (2021) Vol. 8
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

The association between albumin levels and survival in patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis
Deniz Can Güven, Taha Koray Şahin, Enes Erul, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 132
Research progress and value of albumin-related inflammatory markers in the prognosis of non-small cell lung cancer: a review of clinical evidence
Chuanlong Zhang, Mengqi Gao, Xiaochen Jiang, et al.
Annals of Medicine (2023) Vol. 55, Iss. 1, pp. 1294-1307
Open Access | Times Cited: 35
Integration of clinical, pathological, radiological, and transcriptomic data improves prediction for first-line immunotherapy outcome in metastatic non-small cell lung cancer
Nicolas Captier, Marvin Lerousseau, Fanny Orlhac, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Prognostic value of the Scottish Inflammatory prognostic Score in patients with NSCLC expressing PD-L1 ≥ 50 % progressing on first-line pembrolizumab
Mark Stares, Emma Doyle, Sally Chapple, et al.
Lung Cancer (2024) Vol. 189, pp. 107497-107497
Closed Access | Times Cited: 5
Comparison of the cachexia index based on hand-grip strength (H-CXI) with the original CXI for the prediction of cancer cachexia and prognosis in patients who underwent radical colectomy for colorectal cancer
Xialin Yan, Lian‐Ming Wu, Xiu-Bo Tang, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 5
Prognostic significance of hemoglobin, albumin, lymphocyte, and platelet (HALP) score in breast cancer: a propensity score-matching study
Tongchao Jiang, Haishuang Sun, Shuyu Xue, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Exploring Prognostic Factors and Survival Outcomes in Advanced Non-Small Cell Lung Cancer Patients Undergoing First-Line Chemotherapy in Limited-Resource Settings
Chawalit Chayangsu, Jiraporn Khorana, Chaiyut Charoentum, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 335-335
Open Access
The utilization of hypoalbuminemia as a prognostic metric in patients with spinal metastases: A scoping review
Jessica Ryvlin, N. Seneviratne, Ali Haider Bangash, et al.
Brain and Spine (2025) Vol. 5, pp. 104223-104223
Open Access
C-Reactive Protein to Albumin Ratio as Prognostic Marker in Locally Advanced Non-Small Cell Lung Cancer Treated with Chemoradiotherapy
Alina Frey, Daniel Martin, Louisa Abigail D’Cruz, et al.
Biomedicines (2022) Vol. 10, Iss. 3, pp. 598-598
Open Access | Times Cited: 18
Cachexia Index as a Prognostic Indicator in Patients with Gastric Cancer: A Retrospective Study
Can Gong, Qianyi Wan, Rui Zhao, et al.
Cancers (2022) Vol. 14, Iss. 18, pp. 4400-4400
Open Access | Times Cited: 17
Prognostic value of cachexia index in patients with colorectal cancer: A retrospective study
Qianyi Wan, Qian Yuan, Rui Zhao, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 17
Autoencoder-based multimodal prediction of non-small cell lung cancer survival
Jacob G. Ellen, Etai Jacob, Nikos Nikolaou, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Immune-Related Adverse Events, Biomarkers of Systemic Inflammation, and Survival Outcomes in Patients Receiving Pembrolizumab for Non-Small-Cell Lung Cancer
George Raynes, Mark Stares, Samantha Low, et al.
Cancers (2023) Vol. 15, Iss. 23, pp. 5502-5502
Open Access | Times Cited: 9
The Importance of Hypoxia-Related to Hemoglobin Concentration in Breast Cancer
Xinyi Chen, Hongmei Zhou, Jiaoli Lv
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 3, pp. 1893-1906
Closed Access | Times Cited: 3
Hypoalbuminemia and hypercalcemia are independently associated with poor treatment outcomes of anti-PD-1 immune checkpoint inhibitors in patients with recurrent or metastatic head and neck squamous cell carcinoma
Tai-Jan Chiu, Tai‐Lin Huang, Chih‐Yen Chien, et al.
World Journal of Surgical Oncology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Biomarkers of systemic inflammation provide additional prognostic stratification in cancers of unknown primary
Svenja Harvey, Mark Stares, J.A. Scott, et al.
Cancer Medicine (2024) Vol. 13, Iss. 3
Open Access | Times Cited: 2
Appetite in Palliative Cancer Patients and Its Association with Albumin, CRP and Quality of Life in Men and Women—Cross-Sectional Data from the Palliative D-Study
Charlotte Goodrose-Flores, Stephanie E. Bonn, Caritha Klasson, et al.
Life (2022) Vol. 12, Iss. 5, pp. 671-671
Open Access | Times Cited: 9
Optimising Outcomes in Non Small Cell Lung Cancer: Targeting Cancer Cachexia
Iain Phillips, Mark Stares, Lindsay Allan, et al.
Frontiers in Bioscience-Landmark (2022) Vol. 27, Iss. 4
Open Access | Times Cited: 8
Prognostic Value of the Geriatric Nutritional Risk Index in Previously Untreated Patients with Advanced Non-Small Cell Lung Cancer Treated with a Combination Therapy of Anti-PD-1/-PD-L1 Antibodies and Platinum-Based Chemotherapy: A Multicenter Retrospective Study
Taro Hirabayashi, Kei Sonehara, Ryota Ozawa, et al.
Oncology (2024) Vol. 102, Iss. 10, pp. 819-827
Closed Access | Times Cited: 1
Initial active surveillance for patients with metastatic renal cell carcinoma: 10 years' experience at a regional cancer Centre
Mark Stares, Vishwani Chauhan, Jigi Moudgil‐Joshi, et al.
Cancer Medicine (2022) Vol. 12, Iss. 5, pp. 5255-5264
Open Access | Times Cited: 5
Treatment impact of newly approved therapeutic agents for metastatic urothelial carcinoma in Japan: a single-center retrospective study
Yuta Inoue, Takeshi Yamada, Atsuko Fujihara, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Construction and Validation of a Novel Model for Guiding Targeted Combined Immunotherapy in Advanced Hepatocellular Carcinoma
Haibin Tu, Siyi Feng, Lihong Chen, et al.
Research Square (Research Square) (2024)
Open Access
Prognostic Biomarkers of Systemic Inflammation in Non-Small Cell Lung Cancer: A Narrative Review of Challenges and Opportunities
Mark Stares, Leo R. Brown, Dhruv Abhi, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1508-1508
Open Access
The Hammersmith Score optimises patient selection and predicts for overall survival in early-phase cancer trial participants independent of tumour burden
James Korolewicz, Bernhard Scheiner, Claudia Angela Maria Fulgenzi, et al.
Chemotherapy (2024), pp. 1-7
Open Access
Predicting the likelihood of elevated transaminases in lung cancer patients undergoing immune checkpoint blockade
Dmitrii Shek, Bo Gao, Matteo S. Carlino, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1 - Next Page

Scroll to top